Device / Technology News

RSS

FDA approves Teva's ProAir HFA with dose counter for asthma, COPD and EIB

Teva Respiratory announced today that the U.S. Food and Drug Administration (FDA) has approved ProAir HFA with a dose counter for use in patients 4 years of age and older for the treatment or prevention of bronchospasm with reversible obstructive airway disease and for the prevention of exercise-induced bronchospasm.

8 Mar 2012

New precise 3D scanner provides image in 12 seconds

Reliable and highly accurate raw data is needed to use 3D images of a person or object, for example for body measurement. The VITUS smart body scanner from VITRONIC generates an accurate 3D image during a scan of only 12 seconds. VITRONIC will present the VITUS smart body scanner at the 3D Body Scanning Technologies Asian Workshop in Tokyo, Japan.

8 Mar 2012

£1.2 billion over five years to be saved with Telehealth roll out in UK

Telehealth or telecare in health may soon allow people with long term conditions like heart disease, diabetes and chronic obstructive pulmonary disorder (COPD) to manage their illness largely from home feel authorities.

8 Mar 2012

WPI professor receives NSF's CAREER Award for general purpose robots

Sonia Chernova, assistant professor of computer science and robotics engineering at Worcester Polytechnic Institute (WPI), has received a five-year, $500,000 CAREER Award from the National Science Foundation (NSF) to conduct research aimed at paving the way for general purpose robots that can work effectively and productively alongside people in everyday settings.

8 Mar 2012

New inexpensive medical sensor may simplify diagnosis of diseases

An inexpensive new medical sensor has the potential to simplify the diagnosis of diseases ranging from life-threatening immune deficiencies to the common cold, according to its inventors at the Stanford University School of Medicine.

8 Mar 2012

Women with breast pain do not gain benefit from imaging

Researchers from Boston University School of Medicine (BUSM) and Boston Medical Center (BMC) have found that women with breast pain who receive imaging (mammograms, MRIs or ultrasounds) as part of breast pain evaluation, undergo follow-up diagnostic testing, but do not gain benefit from these additional studies.

8 Mar 2012

New minimally invasive procedure can treat resistant hypertension

A radically different approach to treating high blood pressure - using a minimally invasive procedure- is being evaluated as part of a Pivotal Phase III 90-site national trial that includes The Carl H. and Edyth Lindner Center for Research and Education at The Christ Hospital.

8 Mar 2012

People with tinnitus can benefit from internet-based therapy

Those suffering from nagging tinnitus can benefit from internet-based therapy just as much as patients who take part in group therapy sessions. These are the findings of a German-Swedish study in which patients with moderate to severe tinnitus tried out various forms of therapy over a ten-week period.

8 Mar 2012

First 'theranostic' agent for treatment of ALL

A team of researchers at Case Western Reserve University School of Medicine has developed the first "theranostic" agent for the treatment of acute lymphoblastic leukemia (ALL).

8 Mar 2012

NMR techniques shed new light on how pharma molecules adopt different polymorphic forms

Scientists at the University of Warwick have used state-of-the-art nuclear magnetic resonance (NMR) techniques to shed new light on how pharmaceutical molecules pack together in the solid state.

8 Mar 2012

Transcranial direct current stimulation safe and effective treatment for depression

Stimulating the brain with a weak electrical current is a safe and effective treatment for depression and could have other surprise benefits for the body and mind, a major Australian study of transcranial Direct Current Stimulation (tDCS) has found.

7 Mar 2012

FDA approves Covidien's EverFlex Self-Expanding Peripheral Stent System

Covidien, a leading global provider of healthcare products, today announced that the U.S. Food and Drug Administration (FDA) has approved the EverFlex Self-Expanding Peripheral Stent System for use in the superficial femoral artery (SFA) and/or the proximal popliteal artery.

7 Mar 2012

Genesys BioLabs introduces PAULA's test for early lung cancer detection

Genesys BioLabs, a division of 20/20 GeneSystems, Inc. announces today the launch of PAULA's test, a blood test for the early detection of lung cancer, addressing the need for a widely useable early detection protocol for asymptomatic patients.

7 Mar 2012

Illumina launches new highly multiplexed cancer panel

Illumina today introduced the TruSeq Amplicon - Cancer Panel, a highly multiplexed panel that will allow researchers to accurately sequence hundreds of the most relevant cancer loci, even in difficult samples such as formalin-fixed, paraffin embedded (FFPE) tumor samples.

From Illumina, Inc. 7 Mar 2012

Study: Patients need greater access to their electronic medical data

Health care organizations need to do more to help patients realize the full benefits of electronic data from emerging health information exchange systems, according to a new study commissioned by Consumers Union that appears in the March 2012 Health Affairs.

7 Mar 2012

New research provides explanation for some of autism's mysteries

New research from Carnegie Mellon University's Marcel Just provides an explanation for some of autism's mysteries - from social and communication disorders to restricted interests - and gives scientists clear targets for developing intervention and treatment therapies.

7 Mar 2012

e-Health records don't always equal reduced costs

A study published in Health Affairs found that electronic health records don't necessary lead to reducing health care spending or fewer diagnostic tests.

7 Mar 2012

NeuroVista technology shows promise in detecting and predicting seizures

Mayo Clinic and partners from the University of Pennsylvania School of Veterinary Medicine, the University of Minnesota College of Veterinary Medicine and College of Pharmacy, the Perelman School of Medicine at the University of Pennsylvania, and NeuroVista Corporation have been awarded $7.5 million grant (U01) from the National Institute of Neurological Disorders and Stroke, a division of the National Institutes of Health.

7 Mar 2012

A&G, Mayo Medical sign license agreement for new progranulin blood test for FTD

Mayo Clinic today announced that Mayo Medical Laboratories has signed an agreement with A&G Pharmaceutical, Inc. and will receive a non-exclusive license to certain patent rights and proprietary antibody reagents for the detection and measurement of progranulin in blood.

7 Mar 2012

Methodist, UH to improve existing surgical training processes

Measure twice and cut once is a well-known phrase among surgeons, but this is not always what happens. To better prepare new surgeons for the operating room, University of Houston (UH) computer scientists are working with medical researchers at the Methodist Institute for Technology, Innovation and Education (MITIE) to improve existing training processes.

7 Mar 2012